研究单位：[1]Medos International SARL[2]Xuanwu Hospital, Capital Medical University,Beijing,China[3]West China Hospital of Sichuan University,Chengdu,China[4]First Affiliated Hospital, Harbin Medical University,Harbin,China[5]Qilu Hospital of Shandong University,Jinan,China[6]Shandong Provincial Hospital,Jinan,China[7]Nanjing Drum Tower Hospital,Nanjing,China[8]Ningbo First Hospital,Ningbo,China[9]Huashan Hospital Fudan University,Shanghai,China[10]Wenzhou Central Hospital,Wenzhou,China[11]The First Affiliated Hospital of Xi'an Jiaotong University,Xi'an,China[12]The Second Affiliated Hospital of Xi'an Jiaotong University,Xi'an,China
研究目的：
The purpose of this study is to evaluate the safety and effectiveness of CERENOVUS ENTERPRISE 2 intracranial stent implantation in treatment of participants with severe symptomatic intracranial atherosclerotic stenosis.
